GE Global Research scientists will spend the next two years making a “biotic man” for the U.S. military, which would deploy the technology to counter biological warfare attacks.
General Electric Co.’s research and development arm in Niskayuna announced today it will participate in a $1.1 million Defense Department initiative to develop simulation software that models the physiological impacts of biological agents. The technology will also show how those agents respond to new antibiotic and antiviral drug therapies.
To create that software, which would be deployed in battlefield and domestic situations, GE scientists will modify technology they developed in Niskayuna for GE Healthcare-related research. GE will adapt its Physiologically Based Pharmacokinetic software tool, which Niskayuna scientists developed in 2005, for the Defense Department’s Defense Threat Reduction Agency.
That medical software creates computational models that show a drug’s response in the body before clinical trials. The modified software will be part of the Defense Department’s Transformational Medical Technologies Initiative.